Replies to post #15240 on Guided Therapeutics Inc (GTHP)

[myjog]

1 more week’s gone & here we go again. It’s déjà-vu all over again! Stock is down.

Wall Street now suspects that management is collaborating with broker-dealers/market-makers to keep stock price subdued. And Wall Street may very well be right.

Wall Street suspected that management is incompetent & they are right….so far

Wall Street suspected that management is fraudulent & they are right….so far

Wall Street suspected that management are a bunch of thieves & they are right….so far

Can management give stockholders 1 single reason why they think they deserve their positions?

Incompetent management is the biggest hurdle & the biggest road block in starting US clinical trials & the success of this company.

[GetSeriousOK]

Emailing or calling a CEO is a waste of time. They can't tell you anything that isn't already made public.

You asked for a status update on the Chinese clinical trials and the company released a PR to satisfy your request. They can't tell a shareholder information like that before it's made public. And I'm sure they will release a PR about US clinical trials when they are ready.

I'd like to hear how a CEO could steal $3.3 million from the company's assets when the company reports to the SEC and has their books audited. On the other hand, that's so absurd that I probably DON'T want to hear the explanation of how that could possibly happen.

A little DD does wonders to dispel conspiracy theories. For example, the 10-Q offers this fact -- this doesn't sound like the action of a CEO who steals money from his company, IMO:

On July 20, 2018, the Company entered into an exchange agreement with Dr. Cartwright, whereby Dr. Cartwright agreed to exchange outstanding amounts due to him for loans, interest, bonus, salary and vacation pay in the amount of $1,621,499 for a $319,000 promissory note dated September 4, 2018 that incurs interest at a rate of 6% per annum.

https://www.otcmarkets.com/filing/html?id=16018340&guid=vc_-kpF7IUePB3h

I guess investors have to decide: be patient or move on. I'm opting for the patience route.